Kinnate Biopharma Inc. Operating Income 2021-2023 | KNTE
Kinnate Biopharma Inc. operating income from 2021 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
| Kinnate Biopharma Inc. Annual Operating Income (Millions of US $) |
|
|---|---|
| 2023 | $-121 |
| 2022 | $-119 |
| 2021 | $-90 |
| 2020 | $-36 |
| 2019 | $-12 |
| 2018 | $-8 |
| Kinnate Biopharma Inc. Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-19 |
| 2023-09-30 | $-33 |
| 2023-06-30 | $-34 |
| 2023-03-31 | $-35 |
| 2022-12-31 | $-33 |
| 2022-09-30 | $-31 |
| 2022-06-30 | $-27 |
| 2022-03-31 | $-27 |
| 2021-12-31 | $-26 |
| 2021-09-30 | $-25 |
| 2021-06-30 | $-22 |
| 2021-03-31 | $-17 |
| 2020-12-31 | $-14 |
| 2020-09-30 | $-11 |
| 2020-06-30 | $-8 |
| 2020-03-31 | $-4 |
